News | RIVM

Novavax vaccine available

The Novavax vaccine is a protein-based vaccine which can offer an alternative for people who are hesitant about immunisation with an mRNA vaccine or vector vaccine, or for people who have a contraindication for mRNA vaccines.

Vrouw krijgt uitleg over COVID-19 vaccinatie

Flu epidemic seems to be emerging

More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.

RIVM monitoring local radiological measurements in Ukraine

Reports from Ukraine indicate that there was fighting in the vicinity of the Zaporizhzhia nuclear power plant last night. RIVM has been actively monitoring the situation in Ukraine since the start of the disturbances.

General practitioners and occupational physicians not yet connected through Patiëntoverleg app

General practitioners’ (GP) and occupational physicians’ (OP) use of the Patiëntoverleg app is still limited. They are often not yet aware of this app’s existence. These findings are from a study performed by RIVM.

RIVM calls for increased involvement of scientific community in solving plastic crisis

Industry and policymakers are not availing themselves enough of the available scientific knowledge when it comes to smarter ways of dealing with plastics.

People aged 70 and up invited for repeat vaccination against COVID-19

People aged 70 years and older living in the Netherlands may receive an invitation for a repeat booster against COVID-19 from 26 February 2022 on. They can make an appointment for vaccination by the Municipal Public Health Services (GGDs).

https://www.rivm.nl/zorg/organisatie-van-zorg/lerende-evaluatie-juiste-zorg-op-juiste-plek

New criteria for amount of salt, sugar and saturated fat in foods

The National Approach to Product Improvement (Nationale Aanpak Productverbetering, in Dutch NAPV) is set to start this year.

Een consument in de supermarkt leest de ingrediëntenlijst van een voedingsproduct

Decrease in SARS-CoV-2 hospital admissions, fewer people tested

1,214 patients with a SARS-CoV-2 infection were admitted to hospital in the Netherlands in the past week*, a decrease of 12% compared to the week before that.

Impact of coronavirus outbreak on participation in National Immunisation Programme limited

Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).

Vader en moeder spelen met jonge kinderen met speelgoed

Booster vaccination prevents many hospital and ICU admissions

In the period from 26 January to 8 February 2022, the COVID-19 vaccines were 92% effective in preventing hospital admission after the booster, and 55% effective after the basic vaccinations.